David D. Meek - 20 Sep 2021 Form 3 Insider Report for Mirati Therapeutics, Inc.

Role: Chief Executive Officer, Director
Signature: /s/ Vickie Reed, Attorney-inFact
Issuer symbol: N/A
Transactions as of: 20 Sep 2021
Net transactions value: $0
Form type: 3
Filing time: 24 Sep 2021, 17:10:53 UTC
Previous filing: 15 Feb 2022
Next filing: 24 Sep 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No shares are beneficially owned.